Every two weeks, in OMB Watch's e-newsletter The Watcher, we analyze a few recent issues in regulatory policy. Here are the articles from the November 6 issue: Vice President Reemerging in Regulatory Review Meetings Representatives from the office of Vice President Richard Cheney have been involved in three current administration rulemakings. Their presence is indicative of a recent trend in which Cheney has involved his office in high-profile regulations. OIRA has held more than 540 regulatory review meetings since February 2002. A representative from OVP has been present at only 11, about two percent. However, eight of those 11 meetings have occurred since February. Read more... Congress Told of FDA's Lax Inspection of Foreign Drug Makers — Again The Government Accountability Office (GAO) recently told Congress that the U.S. Food and Drug Administration (FDA) inspects an estimated seven percent of foreign drug manufacturing facilities. Read more... CPSC Reform Efforts Progress as Agency Woes Continue On Oct. 30, the Senate Commerce Committee approved by voice vote the CPSC Reform Act of 2007 (S. 2045). Recent high-profile regulatory failures have highlighted the need for expansion of CPSC's authority and resources. Read more... Sign up to receive The Watcher by email here.